Listed

Xtant Medical Holdings, Inc.: Form 10-Q for the period ended Mar 31, 2020

Filed with the SEC on May 7, 2020 and accepted by EDGAR at May 7, 2020, 07:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-01-01 to 2020-03-31$14.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-01-01 to 2020-03-31$5.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-01-01 to 2020-03-31$9.6mus-gaap:GrossProfit
Research and development3 months2020-01-01 to 2020-03-31$245.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-01-01 to 2020-03-31−$1.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-01-01 to 2020-03-31$1.1mus-gaap:InterestExpense
Income tax3 months2020-01-01 to 2020-03-31$22.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-01-01 to 2020-03-31−$2.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-01-01 to 2020-03-31−$0.19us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-01-01 to 2020-03-31−$0.19us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-01-01 to 2020-03-3113,175,345 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2020-01-01 to 2020-03-31−$1.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2020-01-01 to 2020-03-31$258.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-03-31$3.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-03-31$32.1mus-gaap:AssetsCurrent
Total assetsAt period end2020-03-31$42.6mus-gaap:Assets
Current liabilitiesAt period end2020-03-31$10.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-03-31$89.0mus-gaap:Liabilities
Long-term debtAt period end2020-03-31$77.3mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2020-03-31−$46.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-20-007869. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.